284637
7-Aminoheptanoic acid
98%
Synonym(s):
7-Aminooenanthic acid
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Recommended Products
Quality Level
Assay
98%
form
powder
reaction suitability
reaction type: solution phase peptide synthesis
mp
192-195 °C (lit.)
application(s)
peptide synthesis
SMILES string
NCCCCCCC(O)=O
InChI
1S/C7H15NO2/c8-6-4-2-1-3-5-7(9)10/h1-6,8H2,(H,9,10)
InChI key
XDOLZJYETYVRKV-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
Storage Class Code
11 - Combustible Solids
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Is there any need for a TAFI(a) inhibitor as thrombolytic drug?
Thrombosis research, 130(4), 574-575 (2012-07-31)
Biochemistry, 32(14), 3540-3548 (1993-04-13)
The involvement of specific aspartic acid (D) and glutamic acid (E) residues of the recombinant (r) kringle 2 (K2) domain of tissue-type plasminogen activator (tPA) in stabilizing its interaction with omega-amino acid ligands has been assessed by examination of these
Surface interactions of a homologous series of alpha,omega-amino acids on colloidal silver and gold.
Biospectroscopy, 5(1), 9-17 (1999-04-29)
Surface enhanced Raman spectroscopy (SERS) was used to characterize a homologous series of alpha,omega-amino acids on colloidal gold and silver. Raman and SER spectra of the alpha,omega-amino acids, NH2(CH2)nCOOH (n = 3-7), are presented and analyzed, revealing the probable conformations
Biochemistry, 31(47), 11698-11706 (1992-12-01)
The properties of the cationic locus within the recombinant (r) kringle 2 domain (residues 180-261) of tissue-type plasminogen activator ([K2tPA]) that are responsible for stabilization of its interaction with the carboxylate moiety of omega-amino acid ligands have been assessed by
Thrombosis research, 130(4), e222-e228 (2012-07-17)
Thrombin-activatable fibrinolysis inhibitor (TAFI) is a plasma zymogen that is activated by thrombin in plasma. In fibrinolytic processes, carboxy-terminal lysine (Lys) residues in partially degraded fibrin are important sites for plasminogen binding and activation, and an active form of TAFI
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service